Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from PRIMA/ENGOT-OV26/GOG-3012 trial
-
Published:2024-09
Issue:
Volume:
Page:
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Monk B.J., Barretina-Ginesta M.P., Pothuri B., Vergote I.ORCID, Graybill W., Mirza M.R., McCormick C.C., Lorusso D.ORCID, Moore R.G.ORCID, Freyer G., O’Cearbhaill R.E., Heitz F., O’Malley D.M., Redondo A., Shahin M.S., Vulsteke C.ORCID, Bradley W.H., Haslund C.A., Chase D.M.ORCID, Pisano C., Holman L.L., Pérez M. J. Rubio, DiSilvestro P., Gaba L., Herzog T.J., Bruchim I., Compton N., Shtessel L., Malinowska I.A., González-Martín A.ORCID
|
|